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Regulation of cellular adhesion and cytoskeletal dynamics is essential for neurulation, though it remains unclear how these two processes are
coordinated. Members of the Ena/VASP family of proteins are localized to sites of cellular adhesion and actin dynamics and lack of two family
members, Mena and VASP, in mice results in failure of neural tube closure. The precise mechanism by which Ena/VASP proteins regulate this
process, however, is not understood. In this report, we show that Xenopus Ena (Xena) is localized to apical adhesive junctions of neuroepithelial
cells during neurulation and that Xena knockdown disrupts cell behaviors integral to neural tube closure. Changes in the shape of the neural plate
as well as apical constriction within the neural plate are perturbed in Xena knockdown embryos. Additionally, we demonstrate that Xena is
essential for cell–cell adhesion. These results demonstrate that Xena plays an integral role in coordinating the regulation of cytoskeletal dynamics
and cellular adhesion during neurulation in Xenopus.
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Neurulation is the morphogenetic process whereby the flat
neural plate is converted into a closed neural tube (Colas and
Schoenwolf, 2001). Dysregulation of this process results in
neural tube defects (NTDs), a class of birth defects including
anencephaly and spina bifida that occur at a rate of 1:1000 live
births within the human population (Copp et al., 1990; Golden
and Chernoff, 1995). Though the incidence of these defects has
decreased within the population through dietary supplementa-
tion of folate (Czeizel and Dudas, 1992), our understanding of
the cellular and molecular mechanisms underlying the genesis
of these defects remains incomplete.
The cell behaviors underlying neurulation have been well
characterized in a variety of vertebrate systems (Colas and⁎ Corresponding author. Fax: +1 612 625 4648.
E-mail addresses: roff0013@umn.edu (J. Roffers-Agarwal),
jeff.miller@estrellamountain.edu (J.R. Miller).
1 Current address: Estrella Mountain Community College, 3000 N. Dysart
Rd., Avondale, AZ 85392, USA.
0012-1606/$ - see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.12.010Schoenwolf, 2001; Davidson and Keller, 1999). Neural tube
formation begins with the thickening and shaping of the neural
epithelium as cells elongate along their apicobasal axis. Cells of
the neural plate then undergo mediolateral intercalation move-
ments, termed neural convergent extension, which lengthens the
plate along the anterioposterior axis and narrows the plate
mediolaterally. Cells at specific regions called hingepoints then
undergo apical constriction, which bends the neural plate and
elevate the neural folds. Intrinsic and extrinsic forces then
facilitate medial movement of the folds, which then meet and
fuse at the midline. Lastly, the neural tube separates from the
overlying epidermal tissue (Smith and Schoenwolf, 1997). The
successful completion of neural tube closure requires the precise
coordination of several morphogenetic behaviors including
changes in cell migration, shape, and adhesion (Colas and
Schoenwolf, 2001; Davidson and Keller, 1999).
A number of genes have been identified that are required for
neural tube closure and a significant proportion of these genes
encode proteins that regulate the actin cytoskeleton and cell
adhesion. Members of the Planar Cell Polarity (PCP) pathway
(Seifert and Mlodzik, 2007), including strabismus/Van Gogh
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2007), Dishevelled (Wallingford and Harland, 2002; Wang et
al., 2006) and Celsr1/flamingo (Curtin et al., 2003) are required
for neural convergent extension movements. Other regulators of
the cytoskeleton such as vinculin (Xu et al., 1998), Mena/VASP
(Lanier et al., 1999; Menzies et al., 2004), Shroom (Hildebrand
and Soriano, 1999), Marcks (Stumpo et al., 1995) and Abl/Arg
(Koleske et al., 1998) are also necessary for proper neural tube
closure. Furthermore, pharmacological disruption of actin
microfilaments within the neural tube disrupts neurulation
(Schoenwolf et al., 1988; Ybot-Gonzalez and Copp, 1999),
indicating a critical role for the actin cytoskeleton and its
regulation in neural tube closure. Several molecules involved in
adhesion have also been found to be important in neural tube
closure including N-cadherin (Radice et al., 1997) as well as the
loss of a combination of integrins (De Arcangelis et al., 1999).
These reports emphasize the important role of the actin
cytoskeleton and adhesion in regulating neurulation.
Ena/VASP proteins act as regulators of actin dynamics by
binding to actin filaments and promoting filament elongation
while inhibiting branching (Bear et al., 2002). This function is
exemplified by the localization of these proteins to filopodia and
lamellipodia in migrating cells where elongation of actin
filaments is needed to drive extension of the membrane critical
for motility (Bear et al., 2002). Additionally, Ena and VASP are
both localized to adherens junctions, important structures for
cell–cell adhesion (Grevengoed et al., 2001; Vasioukhin et al.,
2000), as well as focal adhesions, structures linking the
cytoskeleton with integrins and the extracellular matrix (Gertler
et al., 1996). These localizations suggest that Ena/VASP
proteins are key links between the actin cytoskeleton and
adhesive structures. Two Ena/VASP family members, Mena
and VASP, are essential for neurulation in the mouse.
Mena−/−VASP−/− progeny die perinatally with defects in
cephalic neural tube closure and craniofacial structures
(Lanier et al., 1999; Menzies et al., 2004). The underlying
cellular mechanism causing these defects has not been fully
examined, but data from work in cultured cells suggests that
Ena/VASP proteins may play an important role in coordinat-
ing actin dynamics and the linkage of the actin cytoskeleton
to cell surface adhesion receptors during neural tube closure.
In this report, we examined the function of Xenopus Ena
(Xena) to gain insights into the molecular mechanisms that
control neural tube closure. We found that Xena is enriched at
apical cell–cell junctions within neuroepithelial cells through-
out neurulation. Knockdown of Xena using an antisense
morpholino disrupts neurulation and blocks several morpho-
genetic events essential for neural tube closure including
changes in the shape of the neural plate and apical constriction
and elevation of the neural folds. Additionally, neuroepithelial
cells in Xena depleted embryos appear loosely adherent and
reaggregation assays demonstrate that Xena is required for
optimal cell–cell adhesion. Together these data demonstrate
that Xena is essential for neural tube closure in Xenopus and
suggest that Xena controls cell behaviors required for
neurulation by regulating the actin cytoskeleton and cellular
adhesion.Materials and methods
Embryos and microinjections
Xenopus laevis embryos were obtained by fertilization of eggs from
females injected with human chorionic gonadotropin (Sigma). Eggs were
dejellied in 2% cysteine (Sigma), cultured in 0.33X MMR (Sive et al., 2000),
and staged according to Nieuwkoop and Faber (1967). Capped mRNA for
microinjections was synthesized using the SP6 mMessage Machine kit
(Ambion) and embryos were injected in 4% ficoll in 0.33XMMR.
Morpholinos (MO) were obtained from Gene Tools (Philomath, OR). Two
MOs were used in this study, a splice blocking MO (sMO) and a translation
blocking MO (MO2). To identify sites of putative introns for targeting by an
antisense morpholino, the cDNA sequence for Xena (Xanthos et al., 2005) was
compared with the genomic sequences for Xenopus tropicalis, mouse and human
Ena. Primers surrounding a likely site for intron 2 were created and used to amplify
and sequence this intron fromX. laevis genomic DNA. The sequencewas then used
to design a MO targeting the splice acceptor site at the boundary of intron 2 and
exon 3 (Xena sMO:CACAAACCCATACCTGGTGATCCT). XenaMO2 targets a
sequence in the 5′-UTR (XenaMO2: TGTGTCTCACTTTGCTCCTCCCCCG),
while misMO2 has 5 basepair mismatches to that target sequence (misMO2:
TGTCTCTGACTTTGGTCCTGCCACG).
Analysis of neural tube phenotypes
Phenotypes of knockdown embryos were scored using the following criteria.
Normal: embryos with elevated neural folds that met at the midline along the entire
length of the embryo.Mild: embryos with elevated neural folds slightly separated.
Moderate: embryos with neural folds moderately separated, anterior folds are
separated by about half the width of the embryo. Severe: embryos with almost no
neural fold elevation, anterior folds are positioned on the lateral sides of the
embryo. Endoderm: failure of blastopore to close and endoderm is exposed.
In situ hybridization
In situ hybridization was carried out as described (Harland, 1991).
Digoxigenin-labeled Sox2 and Pax3 probes were synthesized using a MAXI
Script kit (Ambion) and purified using MEGA Clear columns (Ambion). Probes
were detected by alkaline phosphatase-conjugated anti-digoxigenin (Roche)
using BM Purple substrate (Roche Diagnostics). Photographs of embryos were
taken using a digital camera (Nikon Coolpix). Measurements of gene expression
domains were made using NIH Image J. Statistical analysis was performed using
Microsoft Excel.
Immunofluorescence
Embryos were fixed at appropriate stages in 4% formaldehyde in CSK buffer
(10 mM Hepes pH 7.5, 150 mM sucrose, 100 mM KCl, 2 mM EGTA) for 1 h at
room temperature or in Dent's fix (80% methanol, 20% DMSO) overnight at
4 °C. Whole embryos were washed in PBS and then embedded in 4% agarose in
PBS. Embedded embryos were stored in PBS+0.1% Triton-X100 overnight at
4 °C and subsequently stored in PBS. Embryos were sectioned using a
vibratome into 200 μM sections. Sections were incubated in PBST, 2% BSA,
10% normal goat serum (NGS) to prevent non-specific binding of antibodies.
Staining with primary and secondary (Molecular Probes) antibodies was
performed in PBST, 2% BSA, 10% NGS for 2 h at room temperature. Actin was
visualized using Alexa-568 or Alexa-647 phalloidin (Molecular Probes). Images
were collected using a Zeiss spinning disc confocal microscope and digital
images were processed using Adobe Photoshop. Animal caps were cut at stage 9
using a Gastromaster microdissection instrument (Xenotek Engineering) and
then fixed and stained as above. Neural plates were cut at appropriate stages
using an eyebrow knife and fixed and stained as above.
The following antibodies and dilutions were used: anti-β-catenin mono-
clonal antibody (Santa Cruz Biotechnology, 1:50 dilution), anti-GFP polyclonal
antibody (Santa Cruz Biotechnology, 1:250), anti-Xena polyclonal antibody
(1:100) (Xanthos et al., 2005), anti-β-tubulin monoclonal antibody (E7, 1:50;
Developmental Studies Hybridoma Bank, DSHB developed under the auspices
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Biological Sciences, Iowa City, IA 52242.), and anti-vinculin monoclonal
antibody (VN3-24, 1:25; DSHB).
RT-PCR analysis
RT-PCR analysis was performed using total RNA isolated from whole
embryos and animal caps at the indicated stages. cDNAwas synthesized using
SuperScript III reverse transcriptase (Invitrogen). Primers used for RT-PCR:
sMO forward 5′-CGCGGGGGAGGAGCAAAGTGAGACA-3′ (nucleotides
−28 to −4 in the 5′-UTR of the Xena cDNA) and sMO reverse 5′-
TCCTGGGAGTTCAGCACCTCTAAG-3′ (nucleotides 344 to 321 of the
Xena coding sequence).
Western blot analysis
Animal caps were cut at st. 8 and incubated in 1× Steinberg's until sibling
embryos reached st. 23. Explant lysates were and analyzed by SDS-PAGE and
Western blotting as previously described (Xanthos et al., 2005). The following
antibodies and dilutions were used: anti-Mena monoclonal antibody (1:50,
Lebrand et al., 2004), anti-β-tubulin monoclonal antibody (E7; 1:1000, DSHB).
NIH Image J was used to quantify the amount of protein present and all values
were normalized to beta-tubulin.
Adhesion assay
Animal caps were cut at stage 10.5 and groups of caps were dissociated in 1×
calcium–magnesium free MMR for 30 min until inner cells dissociated. Outer
pigmented cells were removed and the media was replaced with 1× Steinberg's.
Cells were alternately rotated for 5 min, followed by incubation for 30 min
without rotation, six times. Cells were then incubated without rotation and
observed periodically for cell clumping.Results
Xena is enriched at apical cell–cell junctions in neuroepithelial
cells
Previous work showed that Xena transcripts are highly
expressed in the neural plate during neurulation (Xanthos et al.,
2005) and this expression pattern, together with knockout data
from mice (Lanier et al., 1999; Menzies et al., 2004), suggests
that Xena may play a critical role in neurulation. As a first step
in examining the potential function of Xena in neural tube
formation, we characterized the subcellular distribution of Xena
protein in the developing neural plate and neural tube. During
early stages of neurulation (stage 14), Xena is localized to the
cell cortex and is associated with pigment granules within the
cytoplasm (Fig. 1A). β-Catenin, a component of cadherin–
catenin adhesion complexes (Aberle et al., 1996), co-localizes
with Xena at cell–cell junctions (Fig. 1A, right panel). In
addition, vinculin, a known Ena binding partner found within
adherens junction complexes (Vasioukhin et al., 2000), also co-
localizes with Xena at cell–cell contacts (Fig. 1B).
Three hingepoints, two dorsolateral hingepoints and one
midline hingepoint, form during neural tube closure and serve
as nucleating centers for neural plate folding (Schoenwolf and
Smith, 1990a,b). These areas initiate folding and undergo
stereotypical changes in cell shape and actin organization. In a
cross-sectional view, Xena is enriched at the apical surface of
neuroepithelial cells, including at putative hingepoints (Figs.1C–E, arrowheads). Upon fusion of the neural tube, Xena is no
longer enriched at the apical surface, but instead is detected at
lateral cell–cell contacts and is elevated at the basal ends of cells
in the neural tube (Fig. 1F). Together these data demonstrate
that Xena is localized to apical adhesive junctions and sites of
dynamic actin remodeling important for driving cell shape
changes during neural tube formation.
Knockdown of Xena disrupts neural tube closure
Ena/VASP proteins have been found to be critical for neural
tube closure in mice in which removal of both Mena and VASP
causes a high incidence of neural tube defects (Lanier et al.,
1999; Menzies et al., 2004), yet the mechanism by which they
control this process remains unclear. In order to elucidate the
mechanism by which Ena/VASP proteins control neural tube
closure, we investigated the requirement for Xena in neurulation
in Xenopus. We focused on examining the function of Xena
because it is highly expressed in the neural plate, whereas Xe-
nopus VASP (Xvasp) is only weakly expressed in all epithelial
cells throughout early development (K.A. Kragtorp and J.R.
Miller, unpublished data) and Xevl is not expressed until after
neurulation is complete (Wanner et al., 2005). Thus, Xena is the
sole Ena/VASP family member expressed at high levels in the
neuroepithelium and is therefore predicted to be the primary
Ena/VASP protein regulating neurulation in Xenopus.
To analyze the requirement for Xena in neural tube formation,
we designed an antisense morpholino (Xena sMO) that targets the
splice donor site at the boundary of intron 2 and exon 3 (Fig. 2A).
Binding of Xena sMO to the splice donor site of exon 2 is
predicted to cause mis-splicing of exon 1 with exon 3, resulting in
the removal of exon 2. This mis-splicing would remove the
majority of the EVH1 domain, a critical protein–protein
interaction domain, and cause a frameshift resulting in an early
stop codon in the protein. RT-PCR amplification of the region
surrounding the morpholino binding site indicated that injection
of Xena sMO (50 ng) caused a mis-splicing event with the
predicted change in size of the Xena transcript from 370 bp to
201 bp (Fig. 2B). Sequencing of the smaller PCR product
confirmed that injection of Xena sMO caused the expected mis-
splicing of the Xena transcript resulting in the loss of exon 2,
which includes the majority of the EVH1 domain, and a
frameshift, which produces a premature stop codon. Based on
these data, translation of the mis-spliced mRNAwould produce a
truncated protein comprised only of a small portion of the amino
terminus and, as a result, this truncated protein is predicted to be
non-functional. Examination ofXena protein expression in animal
caps by western blot showed that injection of Xena sMO (50 ng)
into the animal pole resulted in a 45% decrease in the levels of all
isoforms of Xena protein and a 58% decrease in a neural specific
isoform of Xena (Supplemental Fig. 1). Thus, Xena protein
expression is significantly decreased upon injection ofXena sMO.
To determine the requirement for Xena in neural tube
formation, Xena sMO (25 ng) was injected at the 4-cell stage
into cells fated to give rise to the neural plate. GFP mRNAwas
co-injected with Xena sMO to ensure proper targeting of the
injections. Consistent with a requirement for Xena in neural
Fig. 1. Spatial distribution of Xena protein within the neural plate during Xenopus development. (A) Xena is localized to sites of cell–cell adhesion at stage 14 in a
dorsal view of the neural plate (arrowheads). (B) Xena and vinculin colocalize at sites of cell–cell adhesion in the neural plate (arrowheads). (C–F) Xena protein was
detected in cross-sections using a polyclonal antibody at (C) stage 14, (D) stage 16, (E) stage 18, (F) and stage 20. Xena is enriched apically in cells of the neural plate
undergoing apical wedging (arrowheads). Scale bar in panels A and B=25 μm. Scale bar in panels C–F=100 μm.
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elevation and mediolateral movement of the neural folds
resulting in embryos with a range of neural tube defects (Fig.
2C). Injection of varying amounts of Xena sMO from 10 ng to
50 ng resulted in dose dependent defects in neural tube closure
ranging from a minor effect on the narrowing of the neural plate
and elevation of the neural folds (10 ng) to a complete block of
neurulation (50 ng) (data not shown). All further experiments
were carried out using the 25 ng dose of Xena sMO.
Classification of the severity of neural tube defects (see
Materials and methods for details) revealed that the majority of
Xena sMO-injected embryos have moderate (24/34, 70.6%;
Fig. 2D) or severe (7/34, 20.6%; Fig. 2D) defects in neural tube
formation, whereas only a small proportion of GFP injected
control siblings have mild defects (1/27, 3.7%; Fig. 2D).Importantly, while overexpression of Xena-GFP RNA alone
does not affect neural tube closure or cause any other gross
morphological phenotypes (data not shown), the phenotype
caused by injection of Xena sMO was rescued by co-injection
of Xena-GFP mRNA. The greatest proportion of co-injected
embryos (19/33, 57.6%; Fig. 2D) had mild neural tube defects, a
lower proportion showed moderate defects (13/33, 39.4%; Fig.
2D), and a very small proportion of embryos displayed severe
defects (1/33, 3.0%; Fig. 2D). Thus, co-injection of Xena-GFP
with Xena sMO resulted in significant rescue of the neural tube
defects, indicating that the observed phenotype is the result of
specific knockdown of Xena by the Xena sMO. The inability to
completely rescue the neural tube phenotype may be due to fact
that Xena-GFP protein aggregates abnormally when over-
expressed in embryos (data not shown).
Fig. 2. Xena knockdown disrupts neural tube formation. (A) Schematic showing target site of the Xena sMO. Binding of Xena sMO to the splice donor site of exon 2 is
predicted to cause mis-splicing of exon 1 to exon 3 and a frameshift, resulting in an early stop codon and production of a non-functional, truncated protein. (B) RT-PCR
analysis shows that injection of 50 ng of Xena sMO causes mis-splicing of Xena transcripts. The predicted mis-spliced product was confirmed by sequencing. (C) Xena
depletion results in failure of neural tube closure. Xena sMO (25 ng) injected embryos at stage 15 (mid-neurulation) and stage 18 (late neurulation) displaying neural
tube closure defects. Dashed lines indicate the borders of the neural folds. (D) Defects caused by Xena sMO injection can be rescued by Xena-GFP mRNA injection
(500 pg). Injection of Xena sMO together with 250 pg of GFP mRNA produced a majority of embryos with moderate to severe neural tube closure defects at stage 19.
Injection of Xena sMO together with Xena-GFP mRNA reduced the severity of the phenotype and produced a majority of embryos with mild neural tube closure
defects. Embryos were scored as described in Materials and methods.
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further confirmed by injection of a second morpholino (Xena
MO2) that binds the 5′UTR and start site of Xena transcripts,
thereby blocking translation of Xena protein. Injection of 25 ng
of Xena MO2 causes a similar phenotype to that seen following
injection of Xena sMO (Supplemental Fig. 2). Defects caused
by injection of Xena MO2 are also rescued by coinjection of
Xena-GFP mRNA and injection of a morpholino with five
nucleotide mismatches (Xena misMO2) does not affect
neurulation (Supplemental Fig. 2). Additionally, injection of
mRNA encoding a dominant negative Mena, Mena TD-GFP
(250 pg, n=25; Vasioukhin et al., 2000), yields similar neural
tube phenotypes (data not shown). Together these data
demonstrate that Xena is required for proper neural tube
formation during Xenopus development.
Xena is required for morphogenesis of the neural plate
The initial shaping of the neural plate requires the
coordination of several morphogenetic behaviors including
changes in cell shape and polarized cell migration. At the onset
of neurulation, neuroepithelial cells become elongated along the
apicobasal axis, causing a thickening and narrowing of the plate
(Schoenwolf and Powers, 1987). This initial elongation of cellsis accompanied by mediolateral intercalation of cells, which
leads to further narrowing and lengthening of the neural plate
(Davidson and Keller, 1999; Schoenwolf and Alvarez, 1989).
These behaviors together contribute to the process of neural
convergent extension, which serves to increase the overall
length of the embryo and to reduce the distance between the
neural folds, enabling them to fuse at the completion of
neurulation (Wallingford and Harland, 2002).
In order to determine the precise role Xena plays in
neurulation, we first examined the expression of two neural
markers, Sox2 and Pax3. Analysis of the pan-neural marker
Sox2 revealed that neural induction is not disrupted in Xena
sMO injected embryos, as Sox2 is highly expressed throughout
the neural plate. However, the area of Sox2 expression was
consistently wider and shorter than controls at early stages of
neurulation (Fig. 3A). Determination of the length–width ratio
(LWR) of Sox2 expression showed that neural plates of Xena
sMO-injected embryos had significantly lower LWRs compared
to their GFP injected control siblings (Fig. 3B). Coinjection of
Xena-GFP mRNAwith Xena sMO resulted in Sox2 expression
domains with higher LWRs, indicating that Xena-GFP can
rescue these defects in neural plate shaping (data not shown).
Additionally, we examined the expression of Pax3, which
marks the dorsal neural tube during later stages of neurulation.
Fig. 3. Xena knockdown disrupts neural plate morphogenesis. (A) Xena sMO injected embryos have wider domains of Sox2 expression compared to control embryos.
(B) Quantification of the length–width ratio (LWR) of Sox2 staining demonstrates that the LWR of Xena sMO injected embryos is significantly smaller than that of
GFP injected controls (GFP n=21, Xena sMO n=25, student's t-test p=6.02678×10−09). (C) Pax3 expression domains are significantly wider in Xena sMO injected
embryos compared to GFP-injected controls. (D) Quantification of distance between neural folds as measured by Pax3 expression (GFP n=17, Xena sMO n=23,
student's t-test p=4.22892×10−08).
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injected embryos appeared farther apart than those in GFP
injected control siblings (Fig. 3C). Quantification of these
results demonstrated that the medial movement of the neural
folds is significantly affected in Xena knockdown embryos
(Fig. 3D). Together, these data provide evidence for a potential
role for Xena in regulating narrowing of the neural plate and
elevation of the neural folds during neurulation.
Xena is required for cellular elongation and apical constriction
One of the cell behaviors underlying the shaping of the
developing neural plate is the elongation of cells along their
apicobasal axis. This elongation must be maintained later in
neurulation and in combination with apical constriction is
required to facilitate folding of the neural plate into the neural
tube. To examine whether Xena might play a role in regulating
cell shape, we examined the morphology of neuroepithelial
cells upon injection of Xena sMO. In control embryos,
neuroepithelial cells are elongated along their apical–basal
axis (Fig. 4A). In contrast, cells targeted by Xena sMO appear
cuboidal or even rounded (Fig. 4B) indicating that Xena
depletion blocks initial apicobasal elongation of cells in the
neural plate.
After the neural plate is initially shaped the neural folds
elevate, causing the neural plate to bend. The bending of theplate is achieved by the apical constriction as well as basal
expansion of neuroepithelial cells (Schoenwolf and Smith,
1990a,b). Apical constriction is dependent on reorganization of
the actin cytoskeleton at apical cell–cell junctions. Since Xena
sMO injected embryos appear to have defects in cell shape and
neural fold elevation, we examined whether Xena is required
for apical constriction during neurulation. Neuroepithelial cells
in GFP injected control embryos appear elongated and their
apical surfaces are highly constricted (Fig. 4A, 16/16 GFP
injected embryos). Cells containing Xena sMO, as revealed by
the GFP tracer, showed little or no apical constriction with very
rounded unelongated cells (Fig. 4B, 20/20 Xena sMO injected
embryos). The absence of apical constriction in Xena sMO
targeted cells coincided with a widening of the neural plate as
well as defects in the elevation of the neural folds at these sites.
Similar defects are observed in Xena MO2 injected embryos
(7/7 affected, data not shown) whereas injection of Xena
misMO2 had no effect on apical constriction (5/5, data not
shown). Additionally, unilateral injection of Xena MO2
blocked elevation of the neural fold only on the injected
side, indicating that Xena is required cell autonomously for
elevation of neural folds (Supplemental Fig. 3). These data
demonstrate that Xena is required for the normal apical
constriction of neuroepithelial cells and suggest that lack of
constriction may lead to defects in the shaping of the neural
plate and elevation of the neural folds.
Fig. 4. Xena is required for changes in cell shape and apical constriction during neurulation. (A) Stage 15 GFP injected control embryo stained for GFP and β-tubulin
to outline cells. In control embryos cells are elongated and apically constricted. (B) In Xena sMO injected embryos, cells appear rounded and fail to undergo apical
constriction. Scale bar=25 μm.
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Actin is highly concentrated at the apical ends of
neuroepithelial cells during apical constriction and neural
plate bending, where it is thought to play a critical role inFig. 5. Xena is required for apical accumulation of actin during apical constriction.
accumulates apically (arrowheads) in cells undergoing apical constriction and persis
control embryo. Actin is concentrated apically in cells undergoing apical constric
accumulation of actin is observed in Xena sMO/GFP positive cells. Xena knockdown
higher density of apical actin in GFP negative cells (arrowheads). Scale bar in panegenerating the physical forces required for bending of the neural
plate and elevation of the neural folds. Since Ena/VASP proteins
are known actin regulatory proteins, we hypothesized that Xena
knockdown may affect apical actin organization. In control
embryos, actin is concentrated apically in the developing neural(A) Distribution of actin during neural tube closure in control embryos. Actin
ts apically until the neural tube is completely fused. (B) Stage 18 GFP injected
tion (arrowhead). (C) Stage 18 Xena sMO/GFP injected embryo. No apical
cells remain cuboidal and fail to undergo apical constriction (bracket). Notice the
l A=100 μm. Scale bar in panels B and C=20 μm.
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of the neural folds is complete (Figs. 5A, B, 13/13 GFP injected
embryos). In contrast, actin does not accumulate apically in
cells containing Xena sMO (Fig. 5C, bracket, 20/20 Xena sMO
injected embryos), though actin does accumulate apically in
neighboring cells lacking Xena sMO (Fig. 5C, arrowhead). The
correlation between the lack of apical actin and defects in apical
constriction suggest that Xena may regulate apical constriction
and bending of the neural plate by facilitating the accumulation
or remodeling of actin at apical cell–cell junctions.
Xena is required for proper cell–cell adhesion
Cell–cell adhesion is important for a number of processes
during neurulation including regulation of cell shape, directed
migration, and apical constriction (Oda and Tsukita, 2001;
Wallingford, 2005). Xena co-localizes with components ofFig. 6. Xena is required for cell–cell adhesion. (A) Reaggregation assays show that d
whereas (B) cells from Xena sMO injected embryos fail to reaggregate and mostly st
Catenin is localized apically at the cortex of cells in the neuroepithelial cells of neural p
α-Catenin is diminished at cell–cell junctions and is distributed cytoplasmically in c
sMO/Xena-GFP injected embryo. α-Catenin is localized cortically in cells containing
cell–cell adhesion when compared to levels in surrounding uninjected cells. Scale badherens junctions in the neural plate (Figs. 1A, B) suggesting
that it may regulate cell behaviors during neurulation through
the modulation of adhesive interactions. To explore this
possibility, we utilized a reaggregation assay to determine
whether Xena is required for cell–cell adhesion. Animal caps
from control and Xena sMO injected embryos were dissociated
in Ca2+/Mg2+-free media and were then transferred to complete
media and allowed to reform cell–cell adhesions. Cells from
control animal caps formed large, tight clumps of cells
indicative of the reformation of strong cell–cell contacts (Fig.
6A). However, cells from Xena sMO-injected animal caps
failed to re-adhere to one another and only formed small,
loosely adherent clumps of cells (Fig. 6B). Consistent with a
role for Xena in cell adhesion, we observed a reduction in the
level of α-catenin in neural plates in cells containing Xena sMO
(Fig. 6D, 4/4 Xena sMO injected embryos) compared to control
GFP injected embryos (Fig. 6C). Additionally, α-catenin levelsissociated cells from control explants form numerous tightly adherent aggregates
ay as single cells. (C) Neural plate of stage 15 GFP-injected control embryo. α-
late (arrowheads). (D) Neural plate of stage 15 Xena sMO/GFP injected embryo.
ells containing Xena sMO/GFP (arrowheads). (E) Neural plate of stage 15 Xena
Xena sMO/Xena-GFP (arrowheads). Notice that α-catenin is enriched at sites of
ar in panels C–E=50 μm.
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Xena-GFP mRNA, indicating that Xena-GFP can rescue the
morpholino induced phenotype (Fig. 6E, 3/3 Xena sMO+Xena-
GFP mRNA injected embryos). These results indicate that Xena
is required for cell–cell adhesion and suggest that impairment of
adhesion in Xena knockdown embryos may have an important
contribution to the observed neural tube defects.
Discussion
In this report we analyzed the role of Xena in regulating
morphogenetic processes during neurulation. We found that
Xena is enriched at apical junctions of cells in the neural plate
during neural tube formation and that knockdown of Xena
disrupts neural tube closure. Examination of neural markers
revealed that remodeling of the neural plate shape appears to be
disrupted. These defects coincide with disruption of cell shape
changes within the neural plate including inhibition of apical
constriction, which coincides with a reduction of apical actin
accumulation. Finally, we observed that Xena depleted cells are
unable to reaggregate, indicating a requirement for Xena in
cell–cell adhesion. Together, these results demonstrate that
Xena is essential for neural tube formation in Xenopus and
provide evidence for a model in which Xena regulates the
morphogenetic processes that drive neurulation through mod-
ulation of the actin cytoskeleton and cellular adhesion.
Our work provides additional evidence supporting an
important role for Ena/VASP proteins in neural tube formation.
Previous studies reported that neural tube closure is disrupted
in Mena−/−;profilin+/− mice (Lanier et al., 1999) and when
Mena and VASP are both removed (Menzies et al., 2004).
These data indicated that Ena/VASP family members play
redundant roles in neural tube formation in mice. In contrast,
we found that knockdown of Xena on its own disrupted neural
tube formation in Xenopus. This lack of redundancy in Xeno-
pus is likely due to the lack expression of other Ena/VASP
family members in the neural plate. Xevl is not expressed until
after neurulation is complete (Wanner et al., 2005) while Xvasp
is expressed at very low levels in all epithelial cells during
neurulation (K.A. Kragtorp and J.R. Miller, unpublished data)
and thus may not be present at levels high enough to
compensate for the loss of Xena. Thus, while the requirement
for Ena/VASP function in neural tube formation in conserved,
changes in the expression levels and/or spatial domains of Ena/
VASP transcripts may account for the lack of redundancy seen
in Xenopus. It will be interesting to see whether Ena is the
primary functional family member during neurulation in other
vertebrates.
The importance of Ena/VASP proteins in various actin-
dependent processes indicates that Xena may regulate multiple
morphogenetic processes during neural tube formation. Ena/
VASP proteins localize to dynamic regions of the cell associated
with increased actin remodeling, such as lamellipodia and
filopodia (Gertler et al., 1996; Rottner et al., 1999) and newly
formed cell–cell adhesions (Scott et al., 2006). Ena/VASP
proteins bind F-actin and are thought to regulate the three
dimensional organization of the actin network within cellularprotrusions (Bear et al., 2002). Additionally, Ena/VASP proteins
are localized to focal adhesions and cell–cell adhesion
complexes where they are thought to modulate the connection
between the actin cytoskeleton and cell surface adhesion
receptors (Kragtorp and Miller, 2006; Reinhard et al., 1992;
Scott et al., 2006; Vasioukhin et al., 2000). Thus, the defects
observed in Xena depleted embryos, including failure of
convergent extension and defects in cell shape and cell
adhesion, suggest that Xena may regulate directed cell
migration, actin-mediated cell shape changes, and cell adhesion
during neural tube formation. The interconnectedness of these
processes, for example cell adhesion is critical for regulating
both cell migration and cell shape, make it difficult to discern
the primary function for Xena during neurulation. Yet, our data
allow us to propose several potential models to explain how
Xena may control cell behaviors required for neural tube
formation.
Neural convergent extension is dependent on polarized cell
motility that drives the narrowing and elongation of the neural
plate. In Xenopus, neuroepithelial cells display monopolar
protrusive activity and migrate towards the dorsal midline to
drive convergent extension of the neural plate (Elul and
Keller, 2000). Neural convergent extension requires PCP
signaling (Ciruna et al., 2006; Curtin et al., 2003; Kibar et al.,
2001; Wallingford and Harland, 2002; Wang et al., 2006) and
is necessary for bringing the neural folds into close enough
proximity to allow the neural folds to meet and fuse at the
midline (Wallingford and Harland, 2002). While we can not
say conclusively that loss of Xena disrupts neural convergent
extension movements, Xena depletion perturbs shaping of the
neural plate indicating that Xena is a component of the
regulatory machinery coordinating cell movements in the
neural plate. The well-established roles for Ena/VASP
proteins in cell migration suggest that Xena may regulate
shaping of the neural plate by modulating actin dynamics at
the leading edge of migrating neuroepithelial cells. Our data
also raise the interesting possibility that PCP signaling may
control protrusive activity by regulating Ena/VASP activity.
Further studies will be required to test this idea and define the
precise role for Xena in controlling shaping of the neural
plate and whether it regulates neural convergent extension
movements.
Apical constriction is a common morphogenetic process
involved in bending epithelial sheets. During neurulation, apical
constriction drives bending of the neural plate at specific
hingepoints, which together with medial movement of the
neural folds promotes the meeting and fusion of the neural folds
at the midline. Apical constriction coincides with apical
accumulation of actin and activation of myosin II (Bertet et
al., 2004; Nikolaidou and Barrett, 2004; Shimizu et al., 2005),
suggesting a mechanism involving myosin-mediated contrac-
tion of the apical actin network. In Xena depleted embryos,
apical constriction fails to occur and as a result elevation of the
neural folds is significantly compromised. Actin fails to
accumulate apically in Xena depleted embryos suggesting that
Xena may be required for the establishment and/or contraction
of the apical actin network. Interestingly, altering Ena/VASP
402 J. Roffers-Agarwal et al. / Developmental Biology 314 (2008) 393–403activity in cultured cells can affect cell contractility (Galler et
al., 2006; Hoffman et al., 2006). Furthermore, recent studies in
Drosophila show that Abelson (Abl) kinase regulates the
localization and activity of Ena to control apical constriction of
the ventral furrow (Fox and Peifer, 2007). Mice lacking Abl and
Arg kinases develop neural tube defects and actin organization
in neuroepithelial cells is altered (Koleske et al., 1998).
Together, these studies indicate that precise regulation of Ena/
VASP activity is required for proper cell contractility and that
Abl-Ena/VASP signaling may represent a conserved mechan-
ism for regulating actin organization during apical constriction.
Whether Ena/VASP and Abl work together with other
modulators of apical constriction such as Shroom (Dietz et
al., 2006; Haigo et al., 2003; Hildebrand, 2005; Hildebrand and
Soriano, 1999; Lee et al., 2007) is an open question. Future
analyses of Ena/VASP function will shed additional insights
into the mechanisms coordinating actin assembly and apical
constriction.
Our work provides support for a key role for Xena in
modulating cell–cell adhesion. Xena is enriched at cell–cell
contacts in the neural plate where it co-localizes with β-catenin
and vinculin. In addition, Xena depleted cells fail to
reaggregate providing direct evidence that Xena is required
for optimal cell–cell adhesion. Studies in mammalian cells
indicate that Ena/VASP proteins promote F-actin accumulation
and assembly at cell–cell contacts and loss of Ena/VASP
function perturbs cell adhesion (Scott et al., 2006; Vasioukhin
et al., 2000). Interestingly, Mena was found to primarily
accumulate at newly formed adhesions (Scott et al., 2006)
suggesting that Ena/VASP proteins may preferentially function
to modulate forming or dynamic adhesions. Morphogenetic
movements are dependent on the making and breaking of
adhesions suggesting that Xena could participate in this
process through a function in modulating cell adhesion in
addition to a role in cell migration. Cell shape changes,
including apical constriction, are also dependent on cell
adhesion. Cell surface adhesion complexes are required to
transmit intracellular forces produced by contraction of the
apical cytoskeleton to the membrane and surrounding cells.
Thus, it is possible that Xena may regulate apical constriction
through modulation of actin organization and/or cell–cell
adhesion. Further work will help define the roles for Xena and
provide mechanistic insights into the conserved mechanisms
that control neural tube formation.
Neurulation is driven by the coordination of several
morphogenetic processes including directed cell migration and
changes in cell shape and adhesion. This study demonstrates
that Xena is a key regulator of neural plate shape changes,
apical constriction, and cellular adhesion during neurulation.
Xena may control these morphogenetic processes by providing
a key regulatory link between the actin cytoskeleton and cell
surface adhesion receptors, highlighting the importance of co-
ordinating the regulation of actin and adhesion during morpho-
genesis. By analyzing the molecular pathways that control
morphogenesis, our work can shed light on the conserved
mechanisms that coordinate cell behaviors to drive neural tube
formation in vertebrates.Acknowledgments
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